Granules India informs about revised press release

18 Apr 2019 Evaluate

Granules India has informed about revised press release, titled ‘Granules India Limited received US FDA approval for Acetaminophen 650 mg, Extended Release Tablets’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

574.35 -12.90 (-2.20%)
19-Mar-2026 13:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.90
Dr. Reddys Lab 1274.40
Cipla 1245.80
Zydus Lifesciences 882.45
Lupin 2262.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×